Huaxin Medical
Mainly engaged in the research and development of Class II and Class III medical devices.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD150—225m (Dealroom.co estimates Sep 2022.)
Xiangtan Hunan (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Series A | |
* | CNY200m | Series A | |
| Total Funding | CAD37.5m | ||